307 related articles for article (PubMed ID: 21353334)
1. A double-blind, randomized controlled trial of clobetasol versus pimecrolimus in patients with vulvar lichen sclerosus.
Goldstein AT; Creasey A; Pfau R; Phillips D; Burrows LJ
J Am Acad Dermatol; 2011 Jun; 64(6):e99-104. PubMed ID: 21353334
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
Funaro D; Lovett A; Leroux N; Powell J
J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
[TBL] [Abstract][Full Text] [Related]
3. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases.
Goldstein AT; Marinoff SC; Christopher K
J Reprod Med; 2004 Oct; 49(10):778-80. PubMed ID: 15568399
[TBL] [Abstract][Full Text] [Related]
4. Open-label trial of cyclosporine for vulvar lichen sclerosus.
Bulbul Baskan E; Turan H; Tunali S; Toker SC; Saricaoglu H
J Am Acad Dermatol; 2007 Aug; 57(2):276-8. PubMed ID: 17442452
[TBL] [Abstract][Full Text] [Related]
5. Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl.
Goldstein AT; Marinoff SC; Christopher K
J Pediatr Adolesc Gynecol; 2004 Feb; 17(1):35-7. PubMed ID: 15010037
[TBL] [Abstract][Full Text] [Related]
6. Topical interventions for genital lichen sclerosus.
Chi CC; Kirtschig G; Baldo M; Brackenbury F; Lewis F; Wojnarowska F
Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD008240. PubMed ID: 22161424
[TBL] [Abstract][Full Text] [Related]
7. An arm-based network meta-analysis on treatments for vulvar lichen sclerosus and a call for development of core outcome sets.
Pergialiotis V; Bellos I; Biliou EC; Varnava P; Mitsopoulou D; Doumouchtsis SK;
Am J Obstet Gynecol; 2020 Jun; 222(6):542-550.e6. PubMed ID: 31697910
[TBL] [Abstract][Full Text] [Related]
8. The treatment of vulvar lichen sclerosus and female sexual dysfunction.
Burrows LJ; Creasey A; Goldstein AT
J Sex Med; 2011 Jan; 8(1):219-22. PubMed ID: 20955314
[TBL] [Abstract][Full Text] [Related]
9. Childhood lichen sclerosus: a long-term follow-up.
Patrizi A; Gurioli C; Medri M; Neri I
Pediatr Dermatol; 2010; 27(1):101-3. PubMed ID: 20199428
[TBL] [Abstract][Full Text] [Related]
10. Lichen sclerosus involving the vagina.
Longinotti M; Schieffer YM; Kaufman RH
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1217-9. PubMed ID: 16260578
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment.
Matsumoto Y; Yamamoto T; Isobe T; Kusunoki T; Tsuboi R
J Dermatol; 2007 Feb; 34(2):114-6. PubMed ID: 17239148
[TBL] [Abstract][Full Text] [Related]
12. Testosterone versus clobetasol for maintenance of vulvar lichen sclerosus associated with variable degrees of squamous cell hyperplasia.
Ayhan A; Guven ES; Guven S; Sakinci M; Dogan NU; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(6):715-9. PubMed ID: 17520405
[TBL] [Abstract][Full Text] [Related]
13. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
[TBL] [Abstract][Full Text] [Related]
14. Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women.
Oskay T; Sezer HK; Genç C; Kutluay L
Int J Dermatol; 2007 May; 46(5):527-32. PubMed ID: 17472689
[TBL] [Abstract][Full Text] [Related]
15. Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment.
Virgili A; Lauriola MM; Mantovani L; Corazza M
Acta Derm Venereol; 2007; 87(1):69-72. PubMed ID: 17225019
[TBL] [Abstract][Full Text] [Related]
16. Testosterone maintenance therapy. Effects on vulvar lichen sclerosus treated with clobetasol propionate.
Cattaneo A; Carli P; De Marco A; Sonni L; Bracco G; De Magnis A; Taddei GL
J Reprod Med; 1996 Feb; 41(2):99-102. PubMed ID: 8656422
[TBL] [Abstract][Full Text] [Related]
17. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus.
Radfar L; Wild RC; Suresh L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb; 105(2):187-93. PubMed ID: 18230389
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life and patient-defined benefit of clobetasol 0.05% in women with chronic lichen sclerosus of the vulva.
Schwegler J; Schwarz J; Eulenburg C; Blome C; Ihnen M; Mahner S; Jaenicke F; Augustin M; Woelber L
Dermatology; 2011; 223(2):152-60. PubMed ID: 21997592
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of topical progesterone versus topical clobetasol propionate in patients with vulvar Lichen sclerosus - A double-blind randomized phase II pilot study.
Günthert AR; Limacher A; Beltraminelli H; Krause E; Mueller MD; Trelle S; Bobos P; Jüni P
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():88-95. PubMed ID: 35290878
[TBL] [Abstract][Full Text] [Related]
20. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
Coskun B; Saral Y; Turgut D
Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
